Results 151 to 160 of about 46,511 (209)

Persistent hepatocyte secretory failure in lopinavir/ritonavir related to drug-induced liver injury: a case report. [PDF]

open access: yesFront Med (Lausanne)
Sun Y   +10 more
europepmc   +1 more source

A preliminary survey on the use of ART among blood donors in Shenzhen China and its implications to blood safety. [PDF]

open access: yesBMC Infect Dis
Wang L   +18 more
europepmc   +1 more source

Correction: Alaei et al. Therapeutic Potential of Targeting the Cytochrome P450 Enzymes Using Lopinavir/Ritonavir in Colorectal Cancer: A Study in Monolayers, Spheroids and In Vivo Models. Cancers 2023, 15, 3939. [PDF]

open access: yesCancers (Basel)
Alaei M   +17 more
europepmc   +1 more source

Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women. [PDF]

open access: yesPharmaceutics
Briceño-Patiño N   +4 more
europepmc   +1 more source

Virological Remission in Two HIV-Infected Children After Early cART in Libreville, Gabon. [PDF]

open access: yesCase Rep Pediatr
Bivigou-Mboumba B   +5 more
europepmc   +1 more source

Fluoxetine inhibits severe acute respiratory syndrome coronavirus 2 replication in vitro.

open access: yesIndian J Pharmacol
Vityala Y   +4 more
europepmc   +1 more source

Pharmacokinetics of dexamethasone in tuberculosis meningitis

open access: yes
Calderin JM   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Lopinavir

Drugs, 2000
Lopinavir is a protease inhibitor with high specificity for HIV-1 protease. Ritonavir strongly inhibits lopinavir metabolism; coadministration of lopinavir and ritonavir in healthy volunteers increased the area under the lopinavir plasma concentration-time curve >100-fold.
M, Hurst, D, Faulds
  +5 more sources

Home - About - Disclaimer - Privacy